APA (7th ed.) Citation

Lee, M. M., Petrie, M. C., Cleland, J. G., Donnelly, P., Francis, M., Hannah, A., . . . Kalra, P. R. (2024). Administration of ferric derisomaltose for iron deficiency and heart failure during hospital admission or at the clinic – insights from the IRONMAN trial. European Journal of Heart Failure, 26(10), 2293. https://doi.org/10.1002/ejhf.3394

Chicago Style (17th ed.) Citation

Lee, Matthew M.Y., et al. "Administration of Ferric Derisomaltose for Iron Deficiency and Heart Failure During Hospital Admission or at the Clinic – insights from the IRONMAN Trial." European Journal of Heart Failure 26, no. 10 (2024): 2293. https://doi.org/10.1002/ejhf.3394.

MLA (9th ed.) Citation

Lee, Matthew M.Y., et al. "Administration of Ferric Derisomaltose for Iron Deficiency and Heart Failure During Hospital Admission or at the Clinic – insights from the IRONMAN Trial." European Journal of Heart Failure, vol. 26, no. 10, 2024, p. 2293, https://doi.org/10.1002/ejhf.3394.